Who to call at Dexcom, Inc., and when
Fundz watches for the moments Dexcom, Inc. starts buying, and tells you who to reach.
- An alert the day Dexcom, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dexcom, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dexcom, Inc.. With Fundz connected, it knows.
Dexcom, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
dexcom.comAI Executive Summary
AI-powered analysis of 8-K filing content
Dexcom's Board increased its size to ten directors and appointed Dr. Euan Ashley as a director, effective October 24, 2025, with a term expiring at the 2026 annual meeting. The filing also reflects committee changes, including Kyle Malady stepping down from the Nominating and Governance Committee while remaining chair of the Technology Committee.
Key Takeaways
The Board expanded from its prior size to ten directors, pursuant to the Amended and Restated Bylaws, and filled the new seat with Dr. Euan Ashley effective immediately.
Dr. Ashley will serve until the 2026 annual meeting of stockholders, so he will likely need to stand for election at that meeting.
3 more takeaways
Related Filings (2)
2 more filings from Dexcom, Inc. in the last 90 days
Filing Overview
What This Means
Dexcom, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.